This dual action makes it different from other drugs used to treat type 2 diabetes, such as GLP-1 receptor agonists like semaglutide
Taking more than the advanced dose rarely leads to faster or better results and significantly increases the risk of side effects (e.g., water retention, numbness, nausea)
evidence is primarily preclinical and from longevity research Ipamorelin + CJC-1295 work synergistically to stimulate natural growth hormone release without significantly raising cortisol or prolactin
Chronic pain management and sleep disorders
Genetic associations with LDL-cholesterol, HDL-cholesterol, and triglycerides were obtained from UK Biobank and a large consortium mainly in Europeans, Global Lipids Genetics Consortium (GLGC) (188,577 participants of European descent and 7898 participants of non-European descent not taking lipid modulating medication [35])